Revlimid and Abscess - a phase IV clinical study of FDA data

Summary:

We study 360,904 people who have side effects when taking Revlimid. Abscess is found, especially among people who are male, 60+ old, have been taking the drug for 1 - 6 months, also take Zometa and have Myelodysplastic syndrome.

The phase IV clinical study analyzes which people take Revlimid and have Abscess. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 28, 2023

360,904 people reported to have side effects when taking Revlimid.
Among them, 200 people (0.06%) have Abscess.

What is Revlimid?

Revlimid has active ingredients of lenalidomide. It is used in multiple myeloma. Currently, eHealthMe is studying from 361,207 Revlimid users.

What is Abscess?

Abscess (pus) is found to be associated with 1,896 drugs and 1,286 conditions by eHealthMe. Currently, we are studying 21,697 people who have Abscess.

Number of Revlimid and Abscess reports submitted per year:

* Approximation only. Some reports may have incomplete information.

Do you take Revlimid and have Abscess?

Check whether Abscess is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Revlimid side effects by duration, gender and age:

Revlimid side effects (361,207 reports)

Abscess treatments and more:

Abscess (21,697 reports)

Common drugs associated with Abscess:

All the drugs that are associated with Abscess:

Abscess (1,896 drugs)

Common conditions associated with Abscess:

All the conditions that are associated with Abscess:

Abscess (1,286 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lenalidomide (the active ingredients of Revlimid) and Revlimid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.